CLINICAL_TRIALS
trial_result
· 2010-02-19
Clinical Trial Update: EPO Deep Tank in Dialysis Subjects [Phase 3]
Summary
Amgen completed a Phase 3 trial of an erythropoietin product in dialysis patients with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED